Health Care Equipment & Supplies · Nasdaq

COOCooper Companies, Inc.

Last close
$62.65 +0.7%
52-week range
$51.01 to $89.83
Market cap
$11.9B
Next earnings
Dec 3 in 17 days

Fiscal 2025 at a glance

Revenue
$4.09B
+5% vs FY24
Net income
$375M
-4% vs FY24
Free cash flow
$434M
+51% vs FY24
Net cash
-$2.44B
Cash $111M, debt $2.55B

Stock price

+47% since Dec 2016

Valuation vs its own 10 years

Below its 10-year median on all 4 multiples

Where each multiple sits today inside its own range since 2017, measured at every quarter end. The thin tick is the median.

P/E, trailing
21.4x
7.0x103x
15th percentile, below its median of 38.2x
Price / sales
2.8x
2.8x7.7x
Lowest point in its range, below its median of 5.4x
EV / EBITDA
16.1x
14.9x27.9x
6th percentile, below its median of 21.7x
Price / free cash flow
17.6x
17.6x146x
Lowest point in its range, below its median of 36.7x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-07-31. Every figure carries its unit.

Valuation

P/E
21.4x
Earnings yield
4.7%
Price / sales
2.8x
Price / book
1.4x
Price / operating cash flow
11.5x
EV / EBITDA
16.1x
EV / sales
3.5x
Free cash flow yield
5.7%

Profitability

Gross margin
65.9%
Operating margin
12.8%
Net margin
13.5%
Return on equity
6.8%
Return on capital
3.7%

Growth per year

Revenue, 3 years
+7.3%
Revenue, 5 years
+11.0%
Revenue, 9 years
+8.5%
EPS, 3 years
-1.2%

Balance sheet

Cash and investments
$155M
Total debt
$3.17B
Net cash
-$3.02B
Debt / equity
0.38x
Current ratio
1.22x

Shares and dividend

Shares outstanding
190M
Share count, 5 years
+0.8%
Beta, 1 year
0.48
Dividend yield
n/a
Dividend per share, TTM
n/a
Payout ratio
n/a

n/a: No dividend

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $1.07B
RevenueNet income
Gross profitLatest quarter $712M
EBITDALatest quarter $317M
Margins67 / 21 / 41%
GrossOperatingNet
Earnings per shareLatest quarter $2.24
Cash flowLatest quarter $342M
OperatingCapexFree
Cash vs debtLatest quarter $155M
Cash and investmentsTotal debt
P/E historyNow 21.4x
P/E, median 38.2x dashed
P/S historyNow 2.8x
P/S, median 5.4x dashed

Where the revenue comes from

Rest of the World went from 21% to 19% of revenue in 3 years

Share of revenue by region, fiscal 2022 to 2025, as reported in the 10-K.

USEuropeRest of the World
FY22
50%30%21%
$3.31B
FY23
50%29%21%
$3.59B
FY24
50%30%20%
$3.90B
FY25
50%31%19%
$4.09B
Fiscal 2025 by region
RegionRevenueSharevs FY24
US$2.05B50.2%+4%
Europe$1.25B30.6%+8%
Rest of the World$785M19.2%+1%

Health Care Equipment & Supplies peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
ABT Abbott Laboratories $188B +10% 13.8%40.4x3.9x 60th percentile
DHR Danaher Corp $164B +6% 20.4%38.1x6.4x 65th percentile
ISRG Intuitive Surgical Inc $154B +20% 28.4%53.7x13.3x 48th percentile
MDT Medtronic plc $132B +10% 18.1%25.3x3.5x 20th percentile
SYK Stryker Corp $118B +8% 20.7%33.0x4.5x 30th percentile
COO Cooper Companies, Inc. $11.9B +5% 12.8%21.4x2.8x 15th percentile

The company

Sector
Health Care
Industry
Health Care Equipment & Supplies
Founded
1958
Headquarters
San Ramon, CA
Fiscal year ends
October
Website
coopercos.com

What it does

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical, which manufactures medical devices and fertility and genomic products for the women's healthcare market.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about COO.

Next report

Reports Dec 3, after the close (in 17 days).

Open the Earnings Hub
Big funds, latest 13F

Held by 404 active funds. Crowd level: quiet.

Open the Smart money tab